BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Avian flu virus
,
Trichostatin A
,
rs3825942
,
PBX1
,
cell-cell adhesion
,
Leukemia
,
Retina
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
amrubicin
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Lower optimal dose of amrubicin for relapsed small-cell lung cancer: a retrospective study.
Treatment outcome after sequential chemotherapy with cisplatin-etoposide, amrubicin and nogitecan in…
Postoperative Relapse of Combined Large‒Cell Neuroendocrine Carcinoma of the Lung with a Remarkable …
Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radi…
Premature phase II study of amrubicin as palliative chemotherapy for previously treated malignant pl…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Amrubicin + Cyclophosphamide in Advanced Solid Organ Malignancies
A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multipl…
Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma
A Phase I Study to Assess the Safety, Pharmacokinetics, and Potential Effects of Amrubicin on the QT…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ